Skip to Content

Mivacurium Chloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M03AC10

CAS registry number (Chemical Abstracts Service)

0106861-44-3

Chemical Formula

C58-H80-Cl2-N2-O14

Molecular Weight

1100

Therapeutic Category

Peripherally acting, non-depolarizing muscle relaxant

Chemical Name

(R)-1,2,3,4-Tetrahydro-2-(3-hydroxypropyl)-6,7-dimetoxy-2-metyl-1-(3,4,5-trimetoxybenzyl)isoquinolinium chloride, (E)-4-octenedioate (2:1)

Foreign Names

  • Mivacurii chloridum (Latin)
  • Mivacurium chlorid (German)
  • Chlorure de mivacurium (French)
  • Cloruro de mivacurio (Spanish)

Generic Names

  • Mivacurium Chloride (OS: BAN, USAN)
  • BW B 1090U (IS: Burroughs Wellcome)
  • BWB 10900 dichloride (IS: Burroughs Wellcome)

Brand Names

  • Mivacron
    Euro Registratie, Netherlands; Glaxo Wellcome, Portugal; Glaxo Wellcome, Romania; GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Finland; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malta; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Poland; GlaxoSmithKline, Sweden; GlaxoSmithKline, South Africa; GlaxoSmithKline Laboratoire Pharmaceutique, France; GlaxoSmithKline Pharma, Austria; GlaxoSmithKline UK, United Kingdom; GSK, Belgium; GSK, Turkey; The Wellcome Foundation, Czech Republic

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide